Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 15 results found. Search for [ Novartis International AG ]

Results 1 to 15 of 15
BusinessToday.In
New Delhi, June 19, 2020
Novartis' board approved appointment of Sanker Parameswaran as an additional director (Independent and Non-Executive) of the company, to hold office for a period of 5 consecutive years with effect from June 22, 2020


Joe C Mathew | PB Jayakumar
March 4, 2020
'Right now, the focus is  about 80% innovative medicines and 20 per cent generics. We have 15 launches coming up in innovative medicines,' Novartis International CEO said


Joe C Mathew and PB Jayakumar
March 3, 2020
Novartis has completed strategic transactions worth over $70 billion since he took charge as CEO in 2018. In an exclusive interview with Business Today's Joe C. Mathew and P.B. Jayakumar, the second generation Indian American speaks about his vision for Novartis, new launches in India and the growing role of its Hyderabad centre


Reuters
New Delhi, February 14, 2020
Generic drugmakers say they currently have enough active pharmaceutical ingredients supplies from China to cover their operations for up to about three months


Nevin John
July 30, 2016
The critical enablers that Mistry found out are: build competent leadership and committed workforce and promote pioneering as Jamsetji Tata built first integrated steel mill, JRD the first airline and Ratan Tata the first Indian passenger car, Tata Indica.


Team BT
November 6, 2014
Prime Minister Narendra Modi's visit to Japan has started paying dividends. SoftBank Corp Chairman & CEO Masayoshi Son has pledged a $10 billion investment in India's IT space.


Nita Bhalla
New Delhi, September 30, 2014
The country's patent law enables domestic firms to produce generic drugs poor people can afford, which undermines the interests of US pharmaceutical companies.


Bill Berkrot
February 8, 2014
The US Chamber of Commerce has requested that India be classified as a Priority Foreign Country, a tag given to the worst offenders when it comes to protecting intellectual property and one that could trigger trade sanctions.


PTI
New Delhi, April 1, 2013
Commerce and Industry Minister Anand Sharma has described the Supreme Court judgement rejecting Novartis AG plea for its cancer drug as \"historic\" and said Indian Patent Law conforms fully with global obligations under the WTO IPR pact - TRIPS.


E Kumar Sharma
April 1, 2013
The ruling could have serious implications for global pharmaceutical companies if other emerging countries adopt similar provisions in their patent law.


BT Online Bureau
New Delhi, April 1, 2013
The Intellectual Property Appellate Board had denied the patent right for the drug to Novartis in 2006. The Swiss pharma major had in 2009 taken its challenge against a law that bans patents on newer forms of known drugs to the Supreme Court.


Associated Press
New Delhi, March 5, 2013
The Intellectual Property Appellate Board has rejected Bayer AG's plea to stop Natco Pharma from producing a cheaper generic version of its patented cancer drug.


Anuradha Shukla
New Delhi, February 16, 2011
Business school students have a reason to rejoice as after years of dull placements corporate houses and placement agencies are once again crowding the corridors with job offers.


Shamni Pande
January 11, 2010
Under Indra Nooyi PepsiCo wants to become a smarter and healthier food and beverages company. Here's the story on how India is at the vanguard of that transition.


E. Kumar Sharma
August 19, 2009
By refocussing its strategies, Natco Pharma has pulled back from the brink of bankruptcy to power ahead in cancer drugs. Now it is looking for niche areas globally. Can it scale up and take on global competition?


PAGES 1 OF 1